Similar Articles
321 Options and survival benefits of conversion therapy for unresectable hepatocellular carcinoma
322 Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study
323 Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo
324 Efficacy and safety of Yangxinshi tablet for chronic heart failure: A systematic review and meta-analysis
325 Application of artificial intelligence in the prediction of immunotherapy efficacy in hepatocellular carcinoma: Current status and prospects
326 Impact of different anastomosis methods on post-recurrence after intestinal resection for Crohn's disease: A meta-analysis
327 Des-gamma-carboxy prothrombin and alpha-fetoprotein levels as biomarkers for hepatocellular carcinoma and their correlation with radiological characteristics
328 Hepatocellular carcinoma and musculoskeletal system: A narrative literature review
329 Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis
330 Hepatitis B virus genotypes in precision medicine of hepatitis B-related hepatocellular carcinoma: Where we are now
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA